Inger Öhman

2.1k total citations
30 papers, 1.5k citations indexed

About

Inger Öhman is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Inger Öhman has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pediatrics, Perinatology and Child Health, 16 papers in Psychiatry and Mental health and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Inger Öhman's work include Pharmacological Effects and Toxicity Studies (23 papers), Epilepsy research and treatment (15 papers) and Pregnancy and Medication Impact (9 papers). Inger Öhman is often cited by papers focused on Pharmacological Effects and Toxicity Studies (23 papers), Epilepsy research and treatment (15 papers) and Pregnancy and Medication Impact (9 papers). Inger Öhman collaborates with scholars based in Sweden, Denmark and Austria. Inger Öhman's co-authors include Torbjörn Tomson, Sigurd Vitols, Anne Sabers, Jakob Christensen, Gerhard Luef, Olof Beck, Birgitta Söderfeldt, Maria Dahlin, Vaiva Petrenaite and R. Palm and has published in prestigious journals such as Neurology, Epilepsia and Toxicology and Applied Pharmacology.

In The Last Decade

Inger Öhman

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inger Öhman Sweden 19 1.2k 951 762 155 94 30 1.5k
A. Bardy Finland 15 1.1k 0.9× 686 0.7× 687 0.9× 42 0.3× 32 0.3× 27 1.4k
Dina Battino Italy 31 3.1k 2.6× 2.5k 2.7× 1.7k 2.2× 271 1.7× 38 0.4× 70 3.5k
Jochen G.W. Theis Canada 11 292 0.2× 110 0.1× 365 0.5× 56 0.4× 61 0.6× 19 677
Natalia Borg Sweden 11 143 0.1× 147 0.2× 111 0.1× 154 1.0× 35 0.4× 22 733
Helga Flachs Denmark 17 359 0.3× 276 0.3× 109 0.1× 93 0.6× 89 0.9× 43 999
Britta Ekqvist Sweden 10 237 0.2× 300 0.3× 122 0.2× 86 0.6× 9 0.1× 13 616
Żaneta Kimber-Trojnar Poland 19 381 0.3× 90 0.1× 143 0.2× 39 0.3× 150 1.6× 63 1.1k
Eric Prommer United States 21 245 0.2× 112 0.1× 201 0.3× 99 0.6× 35 0.4× 64 1.0k
Fred Schobben Netherlands 8 215 0.2× 120 0.1× 187 0.2× 12 0.1× 89 0.9× 14 524
J Oxley United Kingdom 19 791 0.7× 848 0.9× 64 0.1× 115 0.7× 7 0.1× 27 1.0k

Countries citing papers authored by Inger Öhman

Since Specialization
Citations

This map shows the geographic impact of Inger Öhman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Öhman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Öhman more than expected).

Fields of papers citing papers by Inger Öhman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Öhman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Öhman. The network helps show where Inger Öhman may publish in the future.

Co-authorship network of co-authors of Inger Öhman

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Öhman. A scholar is included among the top collaborators of Inger Öhman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Öhman. Inger Öhman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Öhman, Inger, et al.. (2025). UGT polymorphisms and epileptic seizure control in pregnant women treated with Lamotrigine. Epilepsy Research. 213. 107554–107554.
2.
Petrenaite, Vaiva, et al.. (2022). Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients. Epilepsy Research. 182. 106897–106897. 10 indexed citations
3.
Hallberg, Pär, Hans Smedje, Niclas Eriksson, et al.. (2019). Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival. EBioMedicine. 40. 595–604. 36 indexed citations
4.
Öhman, Inger, et al.. (2018). Long-acting olanzapine injection during pregnancy and breastfeeding: a case report. Archives of Women s Mental Health. 21(5). 587–589. 11 indexed citations
5.
Petrenaite, Vaiva, Inger Öhman, Lena Ekström, et al.. (2018). UGT polymorphisms and lamotrigine clearance during pregnancy. Epilepsy Research. 140. 199–208. 31 indexed citations
6.
Tomson, Torbjörn, et al.. (2010). Are lamotrigine kinetics altered in menopause? Observations from a drug monitoring database. Epilepsy & Behavior. 19(1). 86–88. 11 indexed citations
7.
Öhman, Inger, Anne Sabers, Pierre de Flon, Gerhard Luef, & Torbjörn Tomson. (2009). Pharmacokinetics of topiramate during pregnancy. Epilepsy Research. 87(2-3). 124–129. 34 indexed citations
8.
Öhman, Inger, Gerhard Luef, & Torbjörn Tomson. (2008). Effects of pregnancy and contraception on lamotrigine disposition: New insights through analysis of lamotrigine metabolites. Seizure. 17(2). 199–202. 54 indexed citations
9.
Öhman, Inger, Olof Beck, Sigurd Vitols, & Torbjörn Tomson. (2007). Plasma concentrations of lamotrigine and its 2‐N‐glucuronide metabolite during pregnancy in women with epilepsy. Epilepsia. 49(6). 1075–1080. 82 indexed citations
10.
Tomson, Torbjörn, R. Palm, Kristina Källén, et al.. (2007). Pharmacokinetics of Levetiracetam during Pregnancy, Delivery, in the Neonatal Period, and Lactation. Epilepsia. 48(6). 1111–1116. 143 indexed citations
11.
Beck, Olof, Inger Öhman, & Helena K. Nordgren. (2006). Determination of Lamotrigine and its Metabolites in Human Plasma by Liquid Chromatography-Mass Spectrometry. Therapeutic Drug Monitoring. 28(5). 603–607. 48 indexed citations
12.
Lavebratt, Catharina, Fuhua Wang, Tomas Klason, et al.. (2006). Carbamazepine protects against megencephaly and abnormal expression of BDNF and Nogo signaling components in the mceph/mceph mouse. Neurobiology of Disease. 24(2). 374–383. 25 indexed citations
13.
Tomson, Torbjörn, et al.. (2006). Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives. Neurology. 67(7). 1297–1299. 29 indexed citations
14.
Öhman, Inger, Sigurd Vitols, & Torbjörn Tomson. (2005). Pharmacokinetics of Gabapentin during Delivery, in the Neonatal Period, and Lactation: Does a Fetal Accumulation Occur during Pregnancy?. Epilepsia. 46(10). 1621–1624. 90 indexed citations
15.
Dahlin, Maria & Inger Öhman. (2004). Age and antiepileptic drugs influence topiramate plasma levels in children. Pediatric Neurology. 31(4). 248–253. 23 indexed citations
16.
Öhman, Inger, Sigurd Vitols, Gerhard Luef, Birgitta Söderfeldt, & Torbjörn Tomson. (2002). Topiramate Kinetics during Delivery, Lactation, and in the Neonate: Preliminary Observations. Epilepsia. 43(10). 1157–1160. 102 indexed citations
17.
Danielsson, Bengt, et al.. (2000). Pharmacokinetic Data Support Pharmacologically Induced Embryonic Dysrhythmia as Explanation to Fetal Hydantoin Syndrome in Rats. Toxicology and Applied Pharmacology. 163(2). 164–175. 21 indexed citations
18.
Öhman, Inger, Sigurd Vitols, & Torbjörn Tomson. (2000). Lamotrigine in Pregnancy: Pharmacokinetics During Delivery, in the Neonate, and During Lactation. Epilepsia. 41(6). 709–713. 203 indexed citations
19.
20.
Tomson, Torbjörn, Inger Öhman, & Sigurd Vitols. (1997). Lamotrigine in Pregnancy and Lactation: A Case Report. Epilepsia. 38(9). 1039–1041. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Bardy Breakdown of academic impact, for papers by Dina Battino Breakdown of academic impact, for papers by Jochen G.W. Theis Breakdown of academic impact, for papers by Natalia Borg Breakdown of academic impact, for papers by Helga Flachs Breakdown of academic impact, for papers by Britta Ekqvist Breakdown of academic impact, for papers by Żaneta Kimber-Trojnar Breakdown of academic impact, for papers by Eric Prommer Breakdown of academic impact, for papers by Fred Schobben Breakdown of academic impact, for papers by J Oxley
Rankless by CCL
2026